• A potent and selective PAD4 inhibitor demonstrates efficacy comparable to an anti-TNFα biologic in a mouse model of arthritis

15 September 2026 – C4X Discovery Holdings Ltd (“C4XD”), a pioneering Drug Discovery company, today announces further progress in its small molecule PAD4 inhibitor programme. C4XD’s lead compound achieved activity comparable to an anti-TNFα biologic in a mouse collagen-induced arthritis (CIA) model. This result underlines the potential of the company’s oral small molecule programme, which could offer rheumatoid arthritis patients a more convenient alternative to injectable biologic therapy.

Nick Ray, CSO of C4X Discovery, commented: “The demonstration of efficacy in a relevant disease model is a key milestone in any drug discovery project. A lead compound from our small molecule PAD4 inhibitor programme has shown activity at 10mg/kg after oral dosing with activity equivalent to etanercept, an anti TNFα biologic that has been a cornerstone of rheumatoid arthritis treatment for close to three decades. To reach that level with an oral small molecule, coupled with its encouraging selectivity profile, we are confident that a pre-clinical candidate is within reach.”

Emma Blaney, CEO of C4X Discovery, said: “C4XD has a strong track record of partnering pre-clinical programmes at various stages in the drug discovery process; we plan to continue partnering discussions for our PAD4 programme during the remainder of 2026. Additionally, we continue to advance our α4β7 programme whilst holding partnering discussions, alongside recent clinical progress under our AstraZeneca-partnered NRF2 programme1. We’d like to thank our staff and investors for their continued support to advance our programmes so that we can collaborate with the best partners to take them forward into the clinic.”

C4XD’s pipeline spans several high-value immuno-inflammatory indications. The company is currently advancing best-in-class oral α4β7 inhibitors alongside a first-in-class PAD4 programme, encompassing both innovative monotherapies and strategic combination approaches across multiple therapeutic areas.

Rheumatoid arthritis (RA) is a systemic autoimmune disease of the synovial tissue in the joints. Symptoms range from swelling and pain to bone erosion and debilitating joint destruction. Anti-Citrullinated Protein Autoantibodies (ACPAs) are found in up to 70% of RA patients, often years before clinical symptoms appear, suggestive of their role in driving disease2. PAD4 is a key enzyme in the generation of the citrullinated antigens targeted by ACPAs, and in the formation of neutrophil extracellular traps (NETs), which contribute to a range of immune-mediated conditions including lupus, renal, cardiovascular and respiratory diseases. A small molecule PAD4 inhibitor offers pipeline-in-a-product potential across multiple high-value autoimmune and inflammatory indications with considerable unmet need. Alongside our α4β7 programme, PAD4 gives us another complementary mechanism across immuno-inflammatory disease.

  1. https://c4xdiscovery.com/c4x-discovery-to-receive-milestone-payment-for-nrf2-exclusive-worldwide-license-agreement/
  2. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther. 2005;7(5):R949–58. doi: 10.1186/ar1767.

– Ends –

Contacts

C4X Discovery Holdings  
Emma Blaney, Nick Ray, Flora Shimi +44 (0)161 235 5085
   
C4X Discovery Media – ICR Healthcare  
Mary-Jane Elliott, Angela Gray, Tom Daniel +44 (0)203 709 5700

Notes to Editors:

About C4X Discovery

C4X Discovery (C4XD) is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world leading next-generation oral medicines. Our enhanced molecular design capabilities deliver a highly differentiated approach to drug discovery, demonstrated by three high-value programmes successfully out-licensed to date. C4XD’s pipeline of small-molecule programmes spans several high-value immuno-inflammatory indications. The company is currently advancing a best-in-class oral α4β7 programme and a first-in-class PAD4 programme. Our strategy is to move these programmes to candidate stage where we look to out-license or collaborate with the best partners to execute clinical development and commercialisation.

For more information visit us at www.c4xdiscovery.com

LONDON, Sept. 15, 2026 (GLOBE NEWSWIRE) — The global power sector is becoming increasingly central to economic growth as artificial intelligence, digital infrastructure, advanced manufacturing and the electrification of transport, buildings and industry increase demand for stable, reliable and available power. At the same time, geopolitical and policy uncertainty, ageing assets, supply-chain bottlenecks and uneven grid infrastructure are shaping the direction and pace of change, according to the latest Power Market Review published today by Willis, a WTW business (NASDAQ: WTW).

The power insurance market remains highly competitive, as the wider insurance market experiences continued softening. Property capacity is abundant, rates continue to fall and insurers are actively seeking growth. Well-managed power companies with strong loss records, credible valuations and robust engineering information are using the soft market to rebalance their risk strategy, but catastrophe-exposed assets, vulnerable supply chains, emerging technologies and risks with weak maintenance or operational data will continue to attract closer underwriting scrutiny in the year ahead.

Although falling rates may create immediate savings, organisations should be exploring opportunities to leverage today’s market to strengthen resilience and prepare for a future change in the market cycle. Power companies can capitalise on current market conditions by reassessing their program structures and challenging existing pricing and design.

Key findings from the report include:

  • Power investment is not moving in one direction. Technology companies, infrastructure investors and some private equity funds are all looking for ways to improve efficiency, reliability and the carbon profile of power systems. Investment activity is increasingly targeting technologies capable of delivering step-change improvements in power generation and system performance.
  • Nuclear investment is accelerating, but financing remains constrained by concerns over delays, cost overruns and execution risk. The insurance market has an opportunity to help bridge this bankability gap through innovative risk transfer solutions, performance guarantees and portfolio-based approaches that give lenders greater confidence and unlock capital for project delivery.
  • Capacity for coal is still available for well-managed risks, although insurer scrutiny is expected to intensify over time. The best insurance outcomes will depend on how clearly insurance buyers evidence risk quality, asset stewardship, transitional plans, maintenance regimes, business interruption exposures and portfolio-level resilience.
  • For international liability, conditions continue to be increasingly favourable for buyers, due to increasing capacity, heightened competition and greater pricing flexibility. However, certain exposures remain subject to greater underwriting scrutiny such as wildfire and bushfire exposure, grid resilience, failure to supply and coal-related risks.
  • Demand for power continues to increase exponentially, pulling capital into the sector but it remains bound by macro M&A transaction trends. Private equity companies are facing constrained exits, longer holding periods and challenging fundraising conditions. Deal ambition remains, but the route to execution is becoming more selective, more strategic and more dependent on risk quality.

Rob Hale, global head of power and renewable energy, Willis Natural Resources, said: “Current market conditions offer more than the chance to reduce costs, they create an opportunity to challenge insurance program architecture and reinvest into resilience before conditions become more challenging. In an interconnected energy system, insurance is not simply a mechanism for transferring loss. Used strategically, it can support investment, protect capital, strengthen resilience and give power companies greater confidence to grow.

“The companies that benefit the most from this cycle will be those that use today’s conditions to build stronger, better-evidenced and more future-ready risk financing strategies. Innovation and collaboration across all stakeholders in the value chain, including risk intermediaries, will play an increasingly critical role in de-risking investors’ capital and unblocking continued growth.”

The complete report can be downloaded here.

About WTW

At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk, and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce, and maximize performance. Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success—and provide perspective that moves you.

Media Contacts

Jo Barrett
Jo.Barrett@wtwco.com

Lauren David
Lauren.David@wtwco.com

VANCOUVER, British Columbia, Sept. 15, 2026 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (TSX: ELD, NYSE: EGO) (“Eldorado” or the “Company”) today announced it will host a site tour of its Kassandra Mines assets, Skouries and Olympias, from September 15 to 18th, 2026 for analysts and institutional investors. The tour will showcase Eldorado’s exploration activities across Greece.

The site tour presentation is available for download on the Company’s website via the following link: https://www.eldoradogold.com/investors/events-webcasts/greek-asset-site-tour

About Eldorado Gold

Eldorado is a gold, copper and base metals producer with mining, development and exploration operations in Canada, Türkiye, and Greece. The Company has a highly skilled and dedicated workforce, safe and responsible operations, a portfolio of high-quality assets, and long-term partnerships with local communities. Eldorado’s common shares trade on the Toronto Stock Exchange (TSX: ELD) and the New York Stock Exchange (NYSE: EGO).

Contact

Investor Relations
Lynette Gould, VP, Investor Relations, Communications & External Affairs
647 271 2827 or 1 888 353 8166
lynette.gould@eldoradogold.com

Media
Chad Pederson, Director, Communications and Public Affairs
236 885 6251 or 1 888 353 8166
chad.pederson@eldoradogold.com

PRESS RELEASE

Valeo is renewing its employee share offering

Paris, 15 September, 2026— Valeo is launching once again this year its share subscription offering reserved for Group employees. This operation, offered to around 81,000 employees eligible for the offer in 21 countries, aims to associate them over the long term with the Group’s results and development. As of today, one employee out of two holds directly or indirectly shares of Valeo. The employee share ownership rate stood at 5.10% as of June 30,  2026.

The launch of this scheme forms part of the Elevate 2028 initiative, Valeo’s new strategic plan aimed at accelerating its financial trajectory through a steady increase in profitability and a significant rise in cash generation. By giving its employees a stake in the company, the Group reaffirms its confidence in its industrial and technological fundamentals to capitalise on the growth of tomorrow’s mobility.

The capital increase and the delivery of Valeo shares in the framework of the offer are expected to take place on November 18, 2026. The main terms and conditions of this operation are detailed below.

ISSUER

Valeo, a French European Company (Société Européenne) with a share capital of EUR 245,607, 624 having its registered office at 100 rue de Courcelles – 75017 Paris – France, and registered in the trade registry of Paris under number 552 030 967 (the “Company”).

Listed on Euronext Paris (France).

ISIN code: FR0013176526 FR.

PURPOSE OF THE OFFERING

This plan is part of the development of the employee shareholding policy of Valeo in France and abroad with the goal of involving employees in the performance and development of the Group.

CONTEXT OF THE OFFER – SECURITIES OFFERED

The offer is proposed pursuant to Articles L. 3332-18 et seq. of the French Labor Code, in the context of the French Group savings plan (Plan d’Epargne de Groupe, PEG) and the International group savings plan (Plan d’Epargne de Groupe international, PEGI) of Valeo. The subscription of shares is made on the basis of the Company’s shareholder’s authorization given by the 22nd resolution of the General meeting of shareholders held on May 22, 2025. Employees subscribing to the offering outside of France will benefit from the grant of shares for free on the basis of 16th resolution of the General meeting of shareholders of May 21, 2026.

The share subscription offering covers a maximum of 1,200,000 Valeo shares with a nominal value of EUR 1 per share.

The shares will bear immediate dividend entitlements and will be fully fungible with existing shares upon their issuance.

SUBSCRIPTION TERMS

Beneficiaries of the offering

The offering is open to employees having seniority of at least three months, acquired consecutively or not, between January 1, 2025 and the last day of the subscription period with a Valeo Group company member of the PEG or the PEGI, as the case may be. The scope of implementation of the offering comprises the following countries: France, Belgium, Brazil, China, Czech Republic, Egypt, Germany, Hungary, India, Ireland, Italy, Japan, Malaysia, Mexico, Poland, Romania, South Korea, Spain, Thailand, Turkey and USA.

The offer is also open in France to former employees in retirement or pre-retirement and who have kept assets in the PEG since their departure from the group.

Subscription formula

Employees may subscribe shares either through the company shareholding fund (fonds commun de placement d’entreprise, FCPE) “Shares4U Relais 2026” intended to merge with the FCPE “Valeorizon” after the approval of the Supervisory board of the FCPE and of the AMF, or, in some countries, through direct shareholding. The employee’s investment will fluctuate in the same manner as the price of the Valeo share, both as it increases or decreases.

The share subscription allows employees subscribing in the context of the PEG to benefit from a matching contribution from their employer.

Outside of France, employees will be awarded conditional shares for free according to the terms and conditions of the plan rules adopted by the Company. The free shares are existing shares of Valeo repurchased by the Company.

Custody of shares – Exercise of voting rights

Subscription is carried out through an FCPE or, in certain countries, by direct shareholding.

When the shares are subscribed through an FCPE, the voting rights are exercised by the elected members of the Supervisory Board (Conseil de surveillance) of the FCPE.

With regard to the shares subscribed for directly, the voting rights are exercised by the subscribers.

Subscription price

The subscription price was set on September 14, 2026 at 11.46 euros. It corresponds to the average of opening prices of Valeo shares on 20 trading days from August 17, 2026 to September 11, 2026 inclusive, after a discount of 20%.

Subscription period

The beneficiaries may subscribe to the offering from September 15, 2026 (inclusive) to September 29, 2026 (inclusive).

Lock-up of the shares

Subject to specific provisions applicable in certain countries, the FCPE units as well as the shares subscribed directly will be subject to a locked period of approximately  5 years as provided for in the PEG (up to May 31, 2031 inclusive) and the PEGI (up to June 30, 2031 inclusive, and for Belgium until November 18, 2031 inclusive), except in the event of a case providing for early release as provided for in Articles L. 3332-25 and R. 3324-22 of the French Labor Code, and as applicable in different countries of implementation of the offering.

CAPITAL INCREASE AND LISTING OF SHARES

The capital increase and the delivery of Valeo shares under the offer are expected to take place on November 18, 2026. An application for listing on Euronext Paris of the Valeo shares issued in the context of this offering will be filed as soon as possible following the capital increase on the same line of listing as the existing shares.

LEGAL NOTICE

This press release should not be considered as an offer or solicitation for the subscription of Valeo shares.

The offering is strictly reserved to the beneficiaries mentioned in this press release and will be implemented only in countries where such an offering has been registered or notified to the competent local authorities and/or following the approval of a prospectus by the competent local authorities or in consideration of exemption from the requirement to prepare a prospectus or to proceed to registration or notification of the offering. The shares have not and will not be registered under the U.S. Securities Act of 1933 or the laws of any state or territory of the United States.

More generally, the offering will only be conducted in countries where all procedures of registering and/or notifications have been completed and the necessary authorizations have been obtained.

CONTACT

For any questions regarding the offering, beneficiaries may contact their Human Resources manager and/or any other person as indicated in the documentation relating to the offering provided to beneficiaries.

About Valeo

Valeo is a leading global technology company creating innovative solutions and systems for automotive and technology partners worldwide. Valeo is structured around its POWER, BRAIN and LIGHT Divisions, and Valeo Service, the augmented service partner, for the aftermarket and new forms of mobility. 

Valeo is committed to making mobility safer, more sustainable and affordable to all. The Group is playing a vital  role in shaping the Car of Tomorrow: which will be  electrified, safer and software-defined. Valeo is leveraging its global industrial footprint and its technological leadership in electrification, advanced driver assistance systems, lighting and software to capture an increasing share of value per vehicle.

Valeo is listed on the Paris Stock Exchange.

Valeo in brief: €20.9 billion in sales in 2025 | 100,000 employees worldwide | 29 countries | 149 production plants | 59 R&D centers | 19 distribution platforms (as of February 26, 2026).

Learn more at www.valeo.com 

Find all our press releases: https://www.valeo.com/en/press-releases/  

Media Contacts

Dora Khosrof | +33 7 61 52 82 75
Florentina Deca | +33 6 32 13 69 15
Caroline De Gezelle | + 33 7 62 44 17 85
Clémence Le-Roux  | + 33 6 12 18 26 00
press-contact.mailbox@valeo.com

Investor Relations

valeo.corporateaccess.mailbox@valeo.com


In order to secure its communication Valeo certifies its content on Wiztrust. You can check the authenticity on https://www.wiztrust.com/en/

Attachment

WUXI, China, Sept. 15, 2026 (GLOBE NEWSWIRE) — We are advised by HUHUTECH International Group Inc. that journalists and other readers should disregard the news release “HUHUTECH Announced Fourth Purchase Order Awarded to U.S. Subsidiary by Its Arizona-Based Semiconductor Customer” issued July 6, 2026 over GlobeNewswire.

Company Contact

Email: ir@huhutech.com
Website: www.huhutech.com

Investor Relations Contact

Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Phone: +1 (347) 947-2093
Email: matthew@strategic-ir.com
Web: www.strategic-ir.com

WUXI, China, Sept. 15, 2026 (GLOBE NEWSWIRE) — We are advised by HUHUTECH International Group Inc. that journalists and other readers should disregard the news release “HUHUTECH Begins Construction on Fourth Arizona Semiconductor Facility Project as First Three Projects Remain on Track for Completion Before Year-End 2026” issued July 22, 2026 over GlobeNewswire.

Company Contact

Email: ir@huhutech.com
Website: www.huhutech.com

Investor Relations Contact

Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Phone: +1 (347) 947-2093
Email: matthew@strategic-ir.com
Web: www.strategic-ir.com

WUXI, China, Sept. 15, 2026 (GLOBE NEWSWIRE) — We are advised by HUHUTECH International Group Inc. that journalists and other readers should disregard the news release “HUHUTECH Expands Arizona Semiconductor Project Portfolio with Fifth Order Worth Approximately US$1.8 Million” issued August 5, 2026 over GlobeNewswire.

Company Contact

Email: ir@huhutech.com
Website: www.huhutech.com

Investor Relations Contact

Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Phone: +1 (347) 947-2093
Email: matthew@strategic-ir.com
Web: www.strategic-ir.com

WUXI, China, Sept. 15, 2026 (GLOBE NEWSWIRE) — We are advised by HUHUTECH International Group Inc. that journalists and other readers should disregard the news release “HUHUTECH International Group Awarded Follow-On Contract from Anchor Customer to Support Continued Capacity Expansion in the Arizona Semiconductor Corridor” issued May 28, 2026 over GlobeNewswire.

Company Contact

Email: ir@huhutech.com
Website: www.huhutech.com

Investor Relations Contact

Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Phone: +1 (347) 947-2093
Email: matthew@strategic-ir.com
Web: www.strategic-ir.com

WUXI, China, Sept. 15, 2026 (GLOBE NEWSWIRE) — We are advised by HUHUTECH International Group Inc. that journalists and other readers should disregard the news release “HUHUTECH’s U.S. Subsidiary Secures First Order Worth $3.0 Million, Marking a Breakthrough Following Its Nasdaq IPO” issued November 7, 2025 over GlobeNewswire.

Company Contact

Email: ir@huhutech.com
Website: www.huhutech.com

Investor Relations Contact

Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Phone: +1 (347) 947-2093
Email: matthew@strategic-ir.com
Web: www.strategic-ir.com

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

Neuberger Private Equity Partners Announces Transaction in Own Shares

St Peter Port, Guernsey 15 September 2026

Neuberger Private Equity Partners Limited (“NBPE” or the “Company”) today announces details of Class A Shares bought back pursuant to general authority granted by shareholders of the Company on 11 June 2026 and the share buy-back agreement with Jefferies International Limited.

Transaction on London Stock Exchange

Date of purchase of Shares

14 September 2026
Number of Shares purchased

160,000 Class A Shares
Highest price/lowest price paid

£14.70 / £14.40
ISIN for the Shares GG00B1ZBD492

All Class A Shares bought back will be cancelled. Following the cancellation, the number of outstanding Class A Shares is 38,731,702‬. The Company also has 3,150,408 Class A shares held in treasury. For reporting purposes under the FCA’s Disclosure Guidance and Transparency Rules the market should use the figure of 38,731,702 voting rights when determining if they are required to notify their interest in, or a change to their interest in the Company.

For further information, please contact:

NBPE Investor Relations        +44 20 3214 9002
Luke Mason        NBPrivateMarketsIR@nb.com

Oak Group        +44 1481 723450

        NBPEP@oak.group

About Neuberger Private Equity Partners Limited

NBPE invests in direct private equity investments alongside market leading private equity firms globally. NB Alternatives Advisers LLC (the “Investment Manager”), an indirect wholly owned subsidiary of Neuberger Berman Group LLC, is responsible for sourcing, execution and management of NBPE. The vast majority of direct investments are made with no management fee / no carried interest payable to third-party GPs, offering greater fee efficiency than other listed private equity companies. NBPE seeks capital appreciation through growth in net asset value over time while paying a bi-annual dividend.

LEI number: 213800UJH93NH8IOFQ77

About Neuberger
Neuberger is an employee-owned, private, independent investment manager founded in 1939 with approximately 3,000 employees across 26 countries. The firm manages $567 billion of equities, fixed income, private markets, real estate and hedge fund portfolios for global institutions, advisors and individuals. Neuberger’s investment philosophy is founded on active management, fundamental research and engaged ownership. The firm is proud to be recognized for its commitment to its two constituents, clients and employees. Again this past year, we were named Best Asset Manager for Institutional Investors in the US (Crisil Coalition Greenwich) and the #1 Best Place to Work in Money Management (Pensions & Investments, firms with more than 1,000 employees). Neuberger has no corporate parent or unaffiliated external shareholders. Visit www.nb.com for more information, including www.nb.com/disclosure-global-communications for information on awards.
Data as of March 31, 2026.

Media Contacts:
US: Soogyung Jordan: Soogyung.Jordan@nb.com
EMEA: Fiona Kehily: Fiona.Kehily@nb.com

All Neuberger figures are as of March 31, 2026, unless otherwise noted, and are subject to change without notice. The firm data, including employees and assets under management, reflect the collective data of the various affiliated investment advisors who are subsidiaries of Neuberger Berman Group LLC. The company history/timeline includes the history of all the company’s subsidiaries, including predecessor companies and acquisitions.

This material is issued on a limited basis through various global subsidiaries and affiliates of Neuberger Berman Group LLC. Please visit www.nb.com/disclosure-global-communications to learn about each company and the legal restrictions and restrictions. The name “Neuberger Berman” and logo are registered service marks of Neuberger Berman Group LLC.

© 2026 Neuberger Berman Group LLC. All rights reserved.

This press release appears as a matter of record only and does not constitute an offer to sell or a solicitation of an offer to purchase any security.

NBPE is established as a closed-end investment company domiciled in Guernsey. NBPE has received the necessary consent of the Guernsey Financial Services Commission. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. This document is not intended to constitute legal, tax or accounting advice or investment recommendations. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. Statements contained in this document that are not historical facts are based on current expectations, estimates, projections, opinions and beliefs of NBPE’s investment manager. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Additionally, this document contains “forward-looking statements.” Actual events or results or the actual performance of NBPE may differ materially from those reflected or contemplated in such targets or forward-looking statements.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.